key: cord-0766906-yv3cblch
authors: Jagannathan, Ram; DuBose, Christopher W; Mabundo, Lilian S.; Chung, Stephanie T.; Ha, Joon; Sherman, Arthur; Bergman, Michael; Sumner, Anne E
title: The OGTT is highly reproducible in Africans for the diagnosis of diabetes: Implications for treatment and protocol design
date: 2020-10-22
journal: Diabetes Res Clin Pract
DOI: 10.1016/j.diabres.2020.108523
sha: 4abb9db6ae60fbf3128ee93b737c72a42b1ff605
doc_id: 766906
cord_uid: yv3cblch

Whether an OGTT reproducibly detects either type 2 diabetes (T2D) or prediabetes in Africans in unknown. Therefore, 131 Africans had two OGTT. Diagnostic reproducibility for T2D was excellent (κ=0.84), but only moderate for prediabetes (κ=0.51). A single OGTT positive for T2D may be sufficient to guide clinical care and inform epidemiologic study design.

As Africa has the highest global prevalence of people living with type 2 diabetes (T2D) who are undiagnosed, effective screening is essential for both clinical care and resource allocation [1] . As T2D is associated with poor outcomes from COVID-19, diagnosis of T2D has increased urgency [2] . Undiagnosed T2D in African countries is often attributed to a lack of access to care [1] . However, failure of fasting plasma glucose (FPG) and

HbA 1c , to detect early T2D in Africans must be considered [3, 4] .

As early T2D in Africans often occurs with only a 2h glucose (2h-PG) ≥11.1 mmol/L, performance of an OGTT is pivotal [4, 5] . Trust in OGTT results requires knowing whether OGTT results are reproducible. The only African study to assess OGTT diagnostic reproducibility was conducted in pregnant women [6] . Our goals were to determine in an African population the diagnostic reproducibility of the OGTT, primarily for the detection of T2D, and secondarily for prediabetes.

OGTT (75g dextrose) were performed after a 12h fast, 11±7 days apart in 131 Africanborn Blacks who self-identified as healthy and were living in America (age 40±11(mean±SD), range 20-65y, BMI 27.7±4.5, range 19.3-39.5 kg/m 2 , duration of United States residence 0.3 to 43 years). Participants denied a history of T2D or the use of medications or supplements which affect glucose tolerance. Prior to OGTT-1, routine blood tests which documented normal hemoglobin levels, liver, kidney and thyroid function were performed [7] . Glucose tolerance categories were based on International Diabetes Federation (IDF) glucose criteria [1] . The kappa-statistic was used to determine diagnostic reproducibility [8] . The study was approved by the NIH Institutional Review Board (Clinical Trials.gov Identifier: NCT00001853). Informed consent was obtained.

For OGTT-1 and OGTT-2, prevalence of T2D was 23% (30/131) and 18% (23/131), respectively ( Figure) . For prediabetes, prevalence was 24% (31/131) and 28% (37/131), respectively. For normal glucose tolerance (NGT), prevalence was 53% (70/131) and 54% (71/131), respectively. The coefficients of variation for FPG and 2h-PG were 3.7% and 10.6%, respectively. Our secondary finding is that diagnosis of prediabetes by the OGTT is poorly reproducible. However, switching between NGT and prediabetes was highest if FPG at OGTT-1 was between 5.0 and 6.0 mmol/L.

Currently two tests must be positive for the diagnosis of T2D [9] . As 2h-PG ≥11. mmol/L. FPG is often lower in African descent populations than whites [10] . Compared to whites, African descent populations have less hepatic fat, lower triglyceride concentrations, less hepatic glucose production, and greater hepatic insulin sensitivity [11, 12] . These population-based physiologic differences provide a rationale for designing prospective studies with power sufficient to determine the appropriate FPG threshold for the diagnosis of T2D in African descent populations.

As FPG performs poorly as a diagnostic test for asymptomatic T2D in Africans, the value of the cumbersome post-challenge glucose remains. To facilitate the conduct of an OGTT, there is a movement to transition from 2h-OGTT to 1h-OGTT [13] . As the 1h-OGTT has been shown in several populations to provide a post-challenge assessment of glucose tolerance status, determining the 1h-PG concentration predictive of 2h-PG≥11.1 mmol/L in Africans is worthy of investigation [13] .

Fasting Plasma Glucose between 5.0 and 6.0 mmol/L In our secondary analyses, we found that similar to other populations, OGTT reproducibility for the detection of prediabetes was unsatisfactory [14] . To understand why, we examined individuals who had FPG between 5.0 and 6.0 mmol/L and found that they were five times more likely to transition between NGT and prediabetes than individuals with FPG outside of this range. Therefore, low diagnostic reproducibility of prediabetes by the OGTT may be accounted for by frequent transitioning between NGT and prediabetes.

Identifying individuals who frequently transition between NGT and prediabetes is important. Duplicate OGTT performed in China found that individuals with one abnormal OGTT had a worse cardiovascular risk profile than individuals with two normal OGTT [15] . In a longitudinal study of Israeli soldiers, FPG between 5.0 and 6.0 mmol/L, carried a high risk for the future development of T2D [16] . Therefore, it would be valuable to perform prospective studies of Africans with FPG between 5.0 to 6.0 mmol/L to determine if they are at high risk for the development of both T2D and cardiovascular disease.

Based on duplicate OGTT studies in Africans, we have shown that an OGTT reproducibly detects T2D but not prediabetes. As FPG≥7.0 mmol/L, was not found in 80% of those with T2D, appreciating that FPG is not a substitute for the OGTT is 

IDF Diabetes Atlas -9th Edition

Nexus of COVID-19 and diabetes pandemics: Global public health lessons

A1C Underperforms as a Diagnostic Test in Africans Even in the Absence of Nutritional Deficiencies, Anemia and Hemoglobinopathies: Insight From the Africans in America Study

Alternative indices of glucose homeostasis as biochemical diagnostic tests for abnormal glucose tolerance in an African setting

Application of the new ADA criteria for the diagnosis of diabetes to population studies in sub-Saharan Africa

Reproducibility of the 75 g oral glucose tolerance test for the diagnosis of gestational diabetes mellitus in a sub-Saharan African population

Do current guidelines for waist circumference apply to black Africans? Prediction of insulin resistance by waist circumference among Africans living in America

Evaluation of a clinical test. I: assessment of reliability

Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020

Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey

Gluconeogenesis and risk for fasting hyperglycemia in Black and White women

Ethnic differences in the ability of triglyceride levels to identify insulin resistance

Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose ≥ 155 mg/dl (8.6 mmol/L)

Reproducibility of impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) classification: a systematic review. Clinical chemistry and laboratory medicine

The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes and other cardiovascular risk factors

Normal fasting plasma glucose levels and type 2 diabetes in young men